This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Gastroenterology

Coeliac UK and Innovate UK announce £750k boost to research
Coeliac UK and Innovate UK announce £750k boost to research
Patients to take part in landmark irritable bowel syndrome trial
Patients to take part in landmark irritable bowel syndrome trial
Janssen seeks EMA approval of Stelara for adults with ulcerative colitis
Janssen seeks EMA approval of Stelara for adults with ulcerative colitis
Collaborative discovery of microbiome-based biomarkers for IBD
Collaborative discovery of microbiome-based biomarkers for IBD
Inflammatory bowel disease linked to prostate cancer
Inflammatory bowel disease linked to prostate cancer
Online CBT can help treat gastrointestinal disorders in children
Online CBT can help treat gastrointestinal disorders in children
Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease
Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease
Expert analysis: the importance of testing in Crohn’s disease and colitis
Expert analysis: the importance of testing in Crohn’s disease and colitis
Towards a treatment for gluten intolerance
Towards a treatment for gluten intolerance
NHS on track to make £300m in savings after arthritis drug deals
NHS on track to make £300m in savings after arthritis drug deals
First Rare Disease Collaborative Network on refractory coeliac disease commissioned
First Rare Disease Collaborative Network on refractory coeliac disease commissioned
Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation
Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation


Popular articles

Pholcodine containing cough and cold medicines withdrawn from UK market
Ketogenic diet linked to higher LDL cholesterol and increased risk of adverse cardiac events
DNA damage to oral cells similar in never smoking vapers and current smokers
Oral PCSK9 inhibitor significantly lowers LDL cholesterol in adults with hypercholesterolaemia
Both controlled and uncontrolled hypertension in obese patients increase all-cause mortality risk




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora